Mohamed Abdel-Rahman

Dr. Mohamed Abdel-Rahman is a distinguished Research Division Professor at the Ohio State College of Medicine, where he has made significant contributions to the fields of pathology, clinical genetics, and molecular genetics. With a keen focus on molecular diagnosis and treatment targets, Dr. Abdel-Rahman is particularly renowned for his work on ocular melanoma. His research delves into the hereditary predisposition to various cancers, aiming to uncover genetic markers that could lead to early detection and personalized treatment strategies. In addition to his primary role, Dr. Abdel-Rahman holds adjunct appointments in human genetics, which allows him to bridge the gap between genetic research and clinical application. He actively collaborates with oncology colleagues to develop and implement clinical trials aimed at improving the management of uveal melanoma. His interdisciplinary approach has been instrumental in advancing the understanding and treatment of this challenging condition. Dr. Abdel-Rahman is also dedicated to education, imparting his knowledge of Ophthalmic Pathology to ophthalmology residents. His teaching not only covers the theoretical aspects but also emphasizes practical, hands-on experience, preparing the next generation of ophthalmologists to tackle complex cases with confidence and expertise. His professional affiliations are a testament to his commitment to the field. Dr. Abdel-Rahman is an active member of several prestigious organizations, including the American Society of Human Genetics, the American Association for Cancer Research, and the Association for Research in Vision and Ophthalmology. These affiliations provide him with a platform to collaborate with fellow researchers and stay at the forefront of genetic and cancer research. Throughout his career, Dr. Abdel-Rahman has been recognized for his outstanding research contributions. He has received numerous awards, including the Junior Investigator Award from the Ocular Melanoma Foundation and the American Cancer Society. These accolades highlight his dedication to advancing medical science and improving patient outcomes through innovative research and clinical practice.